Recent Advances in the Treatment of Bipolar Depression

This activity is jointly sponsored/co-provided by Global Medical Education and Postgraduate Institute for Medicine.

This activity is supported in part by an independent education grant from Sunovion Pharmaceuticals.

Specialty: Psychiatric Medicine

Release date: June 6, 2014

Valid through: June 30, 2015

Target Audience:

This activity has been designed to meet the educational needs of physicians, PCP's, NP's, PA's, nurses involved in the care of patients with bipolar depression.

Program Overview:

An efficacious long term therapy for bipolar depression remains one of the great unmet needs in the care of patients with bipolar disorder.

Clinicians need to consider not just the short term risk benefit ratio of the currently available efficacious treatments when choosing one for their patients but also long term adverse effects including weight gain, metabolic disturbances and cognitive effects. Of the three FDA approved treatments for bipolar depression there are differences in the side effect profiles which may affect clinician choice.

This program consists of 2 continuing education activites.

Module 1 — Roger McIntyre, MD — 0.75 AMA PRA Category 1™ Credit Hours

Module 2 — Prakash Masand, MD — 0.5 AMA PRA Category 1™ Credit Hours